Information  X 
Enter a valid email address

Novartis Ag Ord Shs (0QLR)

Date Time Source Announcement
18 May 2018 12:18 am
GNW
Novartis and Amgen announce FDA approval of Aim...
17 May 2018 2:00 pm
GNW
Novartis data at ASCO and EHA reinforce company...
16 May 2018 6:15 am
GNW
At the Meet Novartis Management investor event,...
  6:00 am
GNW
Novartis announces changes to the Executive Com...
15 May 2018 9:00 pm
GNW
Novartis successfully completes acquisition of ...
  6:15 am
GNW
Novartis ARROW trial to assess mechanistic supe...
  5:45 am
GNW
Novartis completes tender offer for all outstan...
11 May 2018 11:24 pm
GNW
Novartis announces FDA approval of Gilenya®...
07 May 2018 6:15 am
GNW
Alcon Cares Project 100 Commits to Reducing Cat...
02 May 2018 9:05 pm
GNW
Sandoz receives complete response letter from t...
01 May 2018 9:26 pm
GNW
Kymriah® (tisagenlecleucel), first-in-clas...
  6:00 am
GNW
Novartis provides update on proposed acquisitio...
30 Apr 2018 9:10 pm
GNW
Novartis receives FDA approval of Tafinlar®...
  9:05 pm
GNW
New Novartis Phase III data for brolucizumab de...
25 Apr 2018 6:15 am
GNW
Novartis launches FocalView app, providing oppo...
20 Apr 2018 6:15 am
GNW
New Novartis analyses at AAN show siponimod's e...
19 Apr 2018 6:15 am
GNW
Novartis appoints John Tsai Head of Global Drug...
  6:00 am
GNW
Novartis delivered a strong first quarter and a...
18 Apr 2018 9:01 pm
GNW
Sandoz signs agreement with Pear Therapeutics t...
17 Apr 2018 9:00 pm
GNW
Novartis presents first-of-its-kind evidence at...
  6:15 am
GNW
Novartis renews commitment to malaria eliminati...
  6:00 am
GNW
Novartis tender offer for AveXis commences
16 Apr 2018 6:15 am
GNW
Novartis announces new analysis demonstrating E...
09 Apr 2018 5:45 am
GNW
Novartis enters agreement to acquire AveXis Inc...
04 Apr 2018 4:00 pm
GNW
Novartis announces JAMA Cardiology publication ...
28 Mar 2018 6:15 am
GNW
Novartis to present predictability data for bro...
27 Mar 2018 6:00 am
GNW
Novartis to sell stake in consumer healthcare j...
23 Mar 2018 12:51 pm
GNW
Sandoz receives positive CHMP opinion for propo...
22 Mar 2018 11:30 pm
GNW
Phase III data in The Lancet show Novartis sipo...
  4:30 pm
GNW
Novartis drug Tasigna® approved by FDA to ...
20 Mar 2018 6:15 am
GNW
Novartis teams up with Harvard to develop next ...
12 Mar 2018 6:00 am
GNW
Novartis announces changes to the Executive Com...
07 Mar 2018 6:15 am
GNW
Novartis expands alliance with Science 37 to ad...
06 Mar 2018 6:15 am
GNW
Novartis' Xolair® recommended in new globa...
02 Mar 2018 12:22 pm
GNW
Novartis shareholders approve all resolutions p...
01 Mar 2018 6:15 am
GNW
Novartis and Pear Therapeutics to develop digit...
22 Feb 2018 6:15 am
GNW
Treatment with Novartis' Ultibro® Breezhal...
16 Feb 2018 9:05 pm
GNW
Novartis new Cosentyx® data confirms robus...
  9:05 pm
GNW
Novartis new data show Cosentyx® improved ...
14 Feb 2018 6:15 am
GNW
Novartis forms alliance to develop medicines fo...
13 Feb 2018 6:15 am
GNW
Sandoz announces US FDA approval and launch of ...
08 Feb 2018 6:15 am
GNW
Novartis receives FDA approval for Cosentyx...
01 Feb 2018 9:05 pm
GNW
Novartis completes subsequent offering period o...
31 Jan 2018 10:00 pm
GNW
Novartis announces NEJM publication of updated ...
26 Jan 2018 6:02 pm
GNW
Advanced Accelerator Applications Receives FDA ...
24 Jan 2018 9:00 pm
GNW
Novartis exclusively licenses first ophthalmolo...
  6:00 am
GNW
Novartis delivered good operational performance...
22 Jan 2018 9:35 pm
GNW
Novartis reports erenumab met all primary and s...
  6:00 am
GNW
Novartis completes tender offer for Advanced Ac...
18 Jan 2018 10:30 am
GNW
Sandoz announces exclusive global collaboration...
17 Jan 2018 6:15 am
GNW
Novartis granted US FDA Priority Review for Kym...
16 Jan 2018 6:15 am
GNW
Novartis new data reinforces superiority of Cos...
  6:00 am
GNW
Sandoz regulatory submission for proposed biosi...
11 Jan 2018 6:00 am
GNW
Novartis appoints Elizabeth Barrett as Oncology...
09 Jan 2018 6:15 am
GNW
Novartis advances head-to-head superiority tria...
04 Jan 2018 6:15 am
GNW
Novartis drug Promacta® receives FDA Break...
03 Jan 2018 6:15 am
GNW
Novartis Kisqali® received FDA Breakthroug...
22 Dec 2017 9:42 pm
GNW
Novartis drug Tasigna® is approved by FDA ...
  6:15 am
GNW
Novartis' combination therapy Tafinlar® + ...
15 Dec 2017 6:00 am
GNW
Novartis announces Oncology head to retire
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t